Skip to main content
. 2018 Apr 11;27(2):275–284. doi: 10.1177/0963689717749032

Fig. 4.

Fig. 4.

Intracutaneous irritation study. (A) Observation at the 24th h of administration. (B) Observation at the 48th h of administration. (C) Observation at the 72nd h of administration.